SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-052658
Filing Date
2009-11-18
Accepted
2009-11-18 18:47:01
Documents
2
Period of Report
2009-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - DUNAYEVICH rrd257415.html 4  
1 FORM 4 - DUNAYEVICH rrd257415.xml 4 6838
2 POWER OF ATTORNEY rrd230372_260143.htm EX-24.1 3275
  Complete submission text file 0001181431-09-052658.txt   11958
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OREXIGEN THERAPEUTICS, INC. 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address
DUNAYEVICH EDUARDO (Reporting) CIK: 0001396783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 091194358